EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access · CC BY-NC-ND 4.0

Change in Systemic Medication and its Influence on Intraocular Pressure – Results From the Gutenberg Health Study

Panagiotis Laspas, Alica Hartmann, Ida Scholz, Esther Maria Hoffmann, Anthony P Khawaja, Karl Johannes Lackner, Thomas Münzel, Jasmin Ghaemi Kerahrodi, Irene Schmidtmann, Oliver Tüscher, Jörn Markus Schattenberg, Norbert Pfeiffer und 3 weitere

Investigative Ophthalmology & Visual Science · 2024

DOI: 10.1167/iovs.65.14.4 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Investigative Ophthalmology & Visual Science, 2024. Verfasst von Panagiotis Laspas und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, University Medical Center of the Johannes Gutenberg-University Mainz, Mainz, Germany. Hauptthemen laut MEDLINE: Intraocular Pressure, Tonometry, Ocular, Adrenergic beta-Antagonists. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

The purpose of this study was to investigate the relationship between the change in systemic medication and intraocular pressure (IOP) on a population-based level.

Methods

The Gutenberg Health Study is a population-based prospective observational cohort study in Germany. As part of the baseline examination (2007-2012) and 5-year follow-up examination (2012-2017), IOP was measured by non-contact tonometry. Systemic medication was recorded at both time points. Multivariable regression analyses were carried out to analyze associations. Moreover, we calculated the dose-response relationship for the dosage change of selective beta-blockers with IOP change over 5 years.

Results

The analysis population included 19,161 eyes of 9633 participants. IOP change was lower in participants with new intake of selective beta-blockers (-0.31 mm Hg, P < 0.001) and increased in those with discontinuation of selective beta-blocker intake (+0.28 mm Hg, P = 0.02). Associations between IOP change and statins and calcium channel blockers (CCBs) could be attributed to co-medications. There was a dose-response relationship for change in selective beta-blocker intake and change in IOP (-0.16 mm Hg/100 mg, P = 0.02).

Conclusions

Use of systemic selective beta-blockers is associated with an IOP change on a population level, whereas the association with other systemic medications on IOP change could be explained by co-medication use or change in blood pressure. Patients undergoing IOP monitoring and management should routinely be asked about changes in systemic medications.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Intraocular PressureTonometry, OcularAdrenergic beta-AntagonistsHumansFemaleMaleProspective StudiesMiddle AgedGermanyAgedFollow-Up StudiesAntihypertensive AgentsCalcium Channel BlockersHydroxymethylglutaryl-CoA Reductase InhibitorsAdultDose-Response Relationship, Drug

Substanzen

Adrenergic beta-AntagonistsAntihypertensive AgentsCalcium Channel BlockersHydroxymethylglutaryl-CoA Reductase Inhibitors

Autor:innen und Institutionen

  • Department of Ophthalmology, University Medical Center of the Johannes Gutenberg-University Mainz, Mainz, Germany.
  • NIHR Biomedical Research Centre, Moorfields Eye Hospital NHS Foundation Trust & UCL Institute of Ophthalmology, London, United Kingdom.
  • Institute of Clinical Chemistry and Laboratory Medicine, University Medical Center of the Johannes Gutenberg-University Mainz, Mainz, Germany.
  • Center for Cardiology - Cardiology I, University Medical Center of the Johannes Gutenberg-University Mainz, Mainz, Germany.
  • Department of Psychosomatic Medicine and Psychotherapy, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany.
  • Division of Epidemiology and Health Services Research, Institute of Medical Biostatistics, Epidemiology and Informatics (IMBEI), University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany.

Zitieren

APA

Laspas, P., Hartmann, A., Scholz, I., Hoffmann, E. M., Khawaja, A. P., Lackner, K. J., Münzel, T., Kerahrodi, J. G., Schmidtmann, I., Tüscher, O., Schattenberg, J. M., Pfeiffer, N., Konstantinides, S., Wild, P. S., & Schuster, A. K. (2024). Change in Systemic Medication and its Influence on Intraocular Pressure – Results From the Gutenberg Health Study. Investigative Ophthalmology & Visual Science. https://doi.org/10.1167/iovs.65.14.4

Vancouver

Laspas P, Hartmann A, Scholz I, Hoffmann EM, Khawaja AP, Lackner KJ, et al. Change in Systemic Medication and its Influence on Intraocular Pressure – Results From the Gutenberg Health Study. Investigative Ophthalmology & Visual Science. 2024. doi:10.1167/iovs.65.14.4

BibTeX
@article{Laspas2024,
  author = {Laspas, Panagiotis and Hartmann, Alica and Scholz, Ida and Hoffmann, Esther Maria and Khawaja, Anthony P and Lackner, Karl Johannes and Münzel, Thomas and Kerahrodi, Jasmin Ghaemi and Schmidtmann, Irene and Tüscher, Oliver and Schattenberg, Jörn Markus and Pfeiffer, Norbert and Konstantinides, Stavros and Wild, Philipp Sebastian and Schuster, Alexander Karl-Georg},
  title = {Change in Systemic Medication and its Influence on Intraocular Pressure – Results From the Gutenberg Health Study},
  journal = {Investigative Ophthalmology & Visual Science},
  year = {2024},
  doi = {10.1167/iovs.65.14.4}
}
Kostenlos starten →